Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

SPECTRAL DIAGNOSTICS INC T.SDI

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s): DIAGF

Spectral Diagnostics Inc operates in the in-vitro diagnostic testing market. The Company focuses on the development of diagnostic tests that provide critical information for the early identification of life-threatening disease.
Price: $0.345 | Change: +$0.03 | % Change: +9.52%
Volume: 1.1m | Day High/Low: 0.345/0.29 | 52 Week High/Low: 0.77/0.18

View modes: 
0 stars

750 MIL annual revenue

With a late stage P3 and an 85%+ probability of success trading at a market cap of 40 mil? Either something incredibly, bizarrely, freakishly unusual is afoot or this stock is so tightly controlled...read more
2.5 stars

RE:I like you Techone

Tthanks I think.. lol.. Really, if you are an investor in SDI as I am or are bearish, either way, you need to read pro and con arguments.. Information that I posted on Twitter is more then just what...read more
0 stars

RE:CORMARK

My local soothsayer is prediction $5.00+ by end of summer....  rate and reply
3.5 stars

I like you Techone

You're interesting and a "real pro" Would introducing us to the fraudulent information contained within the seekingalpha report be a "subtle / soft bash" or a full frontal ?  I'm sure it's been...read more
0.5 stars

$DIAGF on Twitter

A bit of exchange on Spectral going on right now on twitter.. One knowledgeble biotech person posting pro (@BiotechSage) and the other guy who was bearish with his piece on seekingalpha...read more
0 stars

CORMARK

anyone reliable have any  information from this " phantom " report  rate and reply
3 stars

Cormark report is not available

Unless you're a licensed broker from what I've been told.  I've also been told that their initial report was over 20 pages long.  That seems like overkill for a company struggling to be worth 40M...read more
3.5 stars

RE:RE:Updated Reports from Cormack and Wedbush

Do you have link to the actual Cormark report  ? Thanks.. As for Wedbush, they have maintained Buy rating.. 12 months target price has been reduced to US $1.35 .. They are more positive of the Ph III...read more
3.5 stars

Not to be rude....

But I'm afraid that this story may be slightly too complicated for some of the "BBS" ( Bullboard Bashing Syndicate )  I might suggest selling the stock and buying something that is easy to get your...read more
1 star

All I know is the price is going in the..

wrong direction...  rate and reply
3 stars

RE:Double digit efficacy and fractional valuation

So does double-digit efficacy mean according to the study criteria that 11% of the people lasted >28days with EAA > 0.4? If they still die then what is the point? If it is so the sepsis is so severe...read more
3 stars

Great post NoHandle - intelligent & articulate - nice mix !

I see 3 options; 1) A full buyout in the $2-$3 range, assuming that there are competitive bids 2)A share consolidation ( that no current retail shareholders will like) a 30 mil financing and a US...read more
3.5 stars

The Cormark Analyst

while very bullish, seems a little put off by the lacjk of clarity in Monday's release. Yet clarity in the news release would mean a public disclosure of the severe reduction in the risk of the trial...read more
3.5 stars

RE:RE:RE:Updated Reports from Cormack and Wedbush

RE:Updated Reports from Cormack and Wedbush Welcome friend, your first post and some good questions.  Not sure about these apparent reports though, do they exist ?  Did the Americans make it to...read more
5 stars

RE:RE:Updated Reports from Cormack and Wedbush

you're a fuking idiot  rate and reply
3 stars

RE:RE:Updated Reports from Cormack and Wedbush

I see 3 options; 1) A full buyout in the $2-$3 range, assuming that there are competitive bids 2)A share consolidation ( that no current retail shareholders will like) a 30 mil financing and a US...read more
0.5 stars

RE:RE:Updated Reports from Cormack and Wedbush

Like it or not but this is now a takeover candidate.  There's just way too much value to be maximized by a deep pocketed company that can ramp up enrollment by four fold.  It's just my humble opinion...read more
3.5 stars

RE:Updated Reports from Cormack and Wedbush

Cormark - See below, nevermind the sh!tbirds adding no value. Sample Size Increased to 650 Patients: Recall, the FDA has allowed Spectral to increase the size of the EUPHRATES trial based upon...read more
3.5 stars

door greeter

nice to hear that this board has door greeters like walmart  rate and reply
2 stars

RE:Updated Reports from Cormack and Wedbush

Welcome friend, your first post and some good questions.  Not sure about these apparent reports though, do they exist ?  Did the Americans make it to the moon or was it vacant land a few miles off...read more